Publications by authors named "Michele G Mandel"
Problem/condition: CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and number of abortion-related deaths in the United States.
Period Covered: 2021.
Description Of System: Each year, CDC requests abortion data from the central health agencies for the 50 states, the District of Columbia, and New York City.
Problem/condition: CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and number of abortion-related deaths in the United States.
Period Covered: 2020.
Description Of System: Each year, CDC requests abortion data from the central health agencies for the 50 states, the District of Columbia, and New York City.
Problem/condition: CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and number of abortion-related deaths in the United States.
Period Covered: 2019.
Description Of System: Each year, CDC requests abortion data from the central health agencies for 50 states, the District of Columbia, and New York City.
Problem/condition: CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and number of abortion-related deaths in the United States.
Period Covered: 2018.
Description Of System: Each year, CDC requests abortion data from the central health agencies for 50 states, the District of Columbia, and New York City.
Problem/condition: Since 1969, CDC has conducted abortion surveillance to document the number and characteristics of women obtaining legal induced abortions in the United States.
Period Covered: 2016.
Description Of System: Each year, CDC requests abortion data from the central health agencies of 52 reporting areas (the 50 states, the District of Columbia, and New York City).
Problem/condition: Since 1969, CDC has conducted abortion surveillance to document the number and characteristics of women obtaining legal induced abortions in the United States.
Period Covered: 2015.
Description Of System: Each year, CDC requests abortion data from the central health agencies of 52 reporting areas (the 50 states, the District of Columbia, and New York City).
Problem/condition: Since 1969, CDC has conducted abortion surveillance to document the number and characteristics of women obtaining legal induced abortions in the United States.
Period Covered: 2014.
Description Of System: Each year, CDC requests abortion data from the central health agencies of 52 reporting areas (the 50 states, the District of Columbia, and New York City).
Problem/condition: Since 1969, CDC has conducted abortion surveillance to document the number and characteristics of women obtaining legal induced abortions in the United States.
Period Covered: 2014.
Description Of System: Each year, CDC requests abortion data from the central health agencies of 52 reporting areas (the 50 states, the District of Columbia, and New York City).
Background: Whether providers who regularly provide family planning services consider contraceptive methods as unsafe for women with obesity is unknown.
Methods: We analyzed questionnaire responses received from December 2009 to March 2010 from 635 office-based physicians and 1323 Title X clinic providers delivering family planning services, who were randomly sampled (response rate 65%) before the release of national evidence-based contraception guidelines. We examined provider and clinical setting characteristics and clinic patient demographics for association with provider misconceptions about safety of combined oral contraceptives (COCs), depot medroxyprogesterone acetate (DMPA), or intrauterine devices (IUDs) for women with obesity.
Objective: Immediate postpartum intrauterine devices (IUDs) have been underutilized in the United States despite their known safety. Understanding how providers' attitudes contribute to underutilization is important in improving access. Our objective was to examine healthcare providers' perceptions of the safety of immediate postpartum IUDs before publication of United States contraceptive guidelines.
View Article and Find Full Text PDFProblem/condition: Since 1969, CDC has conducted abortion surveillance to document the number and characteristics of women obtaining legal induced abortions in the United States.
Period Covered: 2013.
Description Of System: Each year, CDC requests abortion data from the central health agencies of 52 reporting areas (the 50 states, the District of Columbia, and New York City).
Article Synopsis
- The study aimed to investigate how hormonal contraceptive use affects HIV disease progression and the effectiveness of antiretroviral treatment (ART) among women in St. Petersburg, Russia.
- During the study, they found no significant increase in disease progression risk or changes in CD4 cell count associated with hormonal contraceptives compared to nonhormonal methods.
- The results suggest that using hormonal contraceptives does not negatively impact HIV progression or treatment efficacy for women already living with HIV.
Objectives: Previous studies have found social cognitive theory (SCT)-framed interventions are successful for improving condom use and reducing sexually transmitted infections (STIs). We conducted a secondary analysis of behavioural data from the Safe in the City intervention trial (2003-2005) to investigate the influence of SCT constructs on study participants' self-reported use of condoms at last intercourse.
Methods: The main trial was conducted from 2003 to 2005 at three public US STI clinics.
Objective: Health care providers should assess pregnancy in women seeking contraceptive services. Although urine pregnancy tests are available in most U.S.
View Article and Find Full Text PDFBackground: While evidence on the association between oral contraceptive (OC) use and breast cancer generally suggests little or no increased risk, the question of whether breast cancer risk varies by OC formulation remains controversial. Few studies have examined this issue because large samples and extensive OC histories are required.
Study Design: We used data from a multicenter, population-based, case-control investigation.
Background: The HIV epidemic in Russia has increasingly involved reproductive-aged women, which may increase perinatal HIV transmission.
Methods: Standard HIV case-reporting and enhanced perinatal HIV surveillance systems were used for prospective assessment of HIV-infected women giving birth in St. Petersburg, Russia, during 2004-2008.
Objective: To examine the relationship between the use of oral contraceptives and the risk of death from breast cancer.
Methods: We used interview data from the Cancer and Steroid Hormone Study, linked to cancer registry data from the Surveillance, Epidemiology, and End Results Program, to examine the 15-year survival and prior use of oral contraceptives among 4,292 women aged 20 to 54 years when diagnosed with breast cancer from December 1, 1980, to December 31, 1982. Cox proportional hazard models were used to estimate the relative rate of death from breast cancer by oral contraceptive use.
Alcohol exposure and breast cancer: results of the women's contraceptive and reproductive experiences study.
Cancer Epidemiol Biomarkers Prev
December 2004
Objectives: To explore associated biological outcomes and clarify the role of timing of exposure in the alcohol-breast cancer relationship.
Methods: In a population-based study of 4,575 women ages 35 to 64 years diagnosed with invasive breast cancer between 1994 and 1998 and 4,682 controls, we collected details of lifetime alcohol use and factors that could confound or modify the alcohol-breast cancer relationship. We used conditional logistic regression to compute the odds of breast cancer among drinkers relative to nondrinkers at all ages and at ages 35 to 49 and 50 to 64 years separately.
Background: It is uncertain whether the use of an oral contraceptive increases the risk of breast cancer later in life, when the incidence of breast cancer is increased. We conducted a population-based, case-control study to determine the risk of breast cancer among former and current users of oral contraceptives.
Methods: We interviewed women who were 35 to 64 years old.